Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone – results from first‐in‐man and relative bioavailability studies
Year: 2015
Type: article
Study design: Clinical Trial
DOI: 10.1111/fcp.12170
Institution: Bayer (Germany)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Bayer HealthCare
OpenAlex ID: W2180018555
